Molecular Therapy-Oncolytics

Papers
(The H4-Index of Molecular Therapy-Oncolytics is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities98
Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect93
Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism89
Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer77
ENO1 and Cancer76
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications70
M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B62
Carboranes as unique pharmacophores in antitumor medicinal chemistry61
Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy60
Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?55
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer52
The next wave of cellular immunotherapies in pancreatic cancer52
Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges51
CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma51
Mesenchymal Stem Cell-Secreted Exosome Promotes Chemoresistance in Breast Cancer via Enhancing miR-21-5p-Mediated S100A6 Expression48
Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma46
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma45
Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor45
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy44
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy44
Oncolytic herpes virus G47Δ works synergistically with CTLA-4 inhibition via dynamic intratumoral immune modulation44
Novel roles of METTL1/WDR4 in tumor via m7G methylation42
Secretion of bispecific protein of anti-PD-1 fused with TGF-β trap enhances antitumor efficacy of CAR-T cell therapy41
Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways41
Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma41
Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives39
Non-coding RNAs and glioblastoma: Insight into their roles in metastasis38
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials38
Efficacy of cancer-specific anti-podoplanin CAR-T cells and oncolytic herpes virus G47Δ combination therapy against glioblastoma38
Defueling the cancer: ATP synthase as an emerging target in cancer therapy36
Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma36
Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer35
Angiogenesis-related non-coding RNAs and gastrointestinal cancer35
The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice35
A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy35
Inhibition of Autophagy Amplifies Baicalein-Induced Apoptosis in Human Colorectal Cancer35
0.20078706741333